Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EPS (Basic): 2019-2025

Historic EPS (Basic) for Legend Biotech (LEGN) over the last 6 years, with Sep 2025 value amounting to -$0.11.

  • Legend Biotech's EPS (Basic) rose 67.65% to -$0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.04, marking a year-over-year increase of 82.73%. This contributed to the annual value of -$0.48 for FY2024, which is 67.35% up from last year.
  • Latest data reveals that Legend Biotech reported EPS (Basic) of -$0.11 as of Q3 2025, which was up 60.71% from -$0.28 recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's EPS (Basic) peaked at $0.84 during Q2 2022, and registered a low of -$0.45 during Q3 2021.
  • In the last 3 years, Legend Biotech's EPS (Basic) had a median value of $0.08 in 2024 and averaged $0.08.
  • Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 620.00% in 2021, then soared by 20,184.68% in 2024.
  • Legend Biotech's EPS (Basic) (Quarterly) stood at -$0.36 in 2021, then fell by 22.27% to -$0.44 in 2022, then spiked by 99.91% to -$0.00 in 2023, then spiked by 20,184.68% to $0.08 in 2024, then surged by 67.65% to -$0.11 in 2025.
  • Its last three reported values are -$0.11 in Q3 2025, -$0.28 for Q2 2025, and $0.27 during Q1 2025.